Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
Sharps Technology, Inc. (STSS)
Saba Capital Management, L.P. — 10% Owner
Shares
77,688
Price
$2.25
Total Value
$174.80K
Shares Held After
1,549,170
% of Holdings
4.8%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
35,003
Price
$28.99
Total Value
$1.01M
Shares Held After
542,761
% of Holdings
6.1%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
14,997
Price
$28.60
Total Value
$428.91K
Shares Held After
577,764
% of Holdings
2.5%
Arcellx, Inc. (ACLX)
Heery Christopher — CHIEF MEDICAL OFFICER
Shares
5,882
Price
$68.51
Total Value
$403.00K
Shares Held After
23,749
% of Holdings
19.9%
Movano Inc. (MOVE)
Leabman Michael Aaron — Director
Shares
6,845
Price
$6.66
Total Value
$45.59K
Shares Held After
22,639
% of Holdings
23.2%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
1,084
Price
$2.50
Total Value
$2.71K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
26,105
Price
$4.89
Total Value
$127.65K
Shares Held After
682,482
% of Holdings
3.7%
Olema Pharmaceuticals, Inc. (OLMA)
Kovacs Shane William Charles — CH. OPERATING & FINANCIAL OFF.
Shares
3,822
Price
$28.01
Total Value
$107.05K
Shares Held After
239,727
% of Holdings
1.6%
Scholar Rock Holding Corp (SRRK)
Sinha Vikas — Chief Financial Officer
Shares
16,755
Price
$42.70
Total Value
$715.44K
Shares Held After
583,245
% of Holdings
2.8%
Scholar Rock Holding Corp (SRRK)
Woods Keith — Chief Operating Officer
Shares
16,746
Price
$42.70
Total Value
$715.05K
Shares Held After
583,254
% of Holdings
2.8%
Scholar Rock Holding Corp (SRRK)
Vaishnaw Akshay — Director
Shares
20,438
Price
$42.70
Total Value
$872.70K
Shares Held After
595,767
% of Holdings
3.3%
Scholar Rock Holding Corp (SRRK)
Hallal David — Director
Shares
57,450
Price
$42.70
Total Value
$2.45M
Shares Held After
1,541,645
% of Holdings
3.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
7,709
Price
$32.75
Total Value
$252.47K
Shares Held After
61,804
% of Holdings
11.1%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
660
Price
$29.99
Total Value
$19.79K
Shares Held After
37,119
% of Holdings
1.7%
Warby Parker Inc. (WRBY)
Gilboa David Abraham — Director
Shares
80,094
Price
$29.46
Total Value
$2.36M
Shares Held After
37,247
% of Holdings
68.3%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
7,551
Price
$40.32
Total Value
$304.42K
Shares Held After
31,108
% of Holdings
19.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
43,198
Price
$0.55
Total Value
$23.76K
Shares Held After
2,266,671
% of Holdings
1.9%
Innovative Eyewear, Inc. (LUCY)
Gayle Oswald — Chief Financial Officer
Shares
300
Price
$1.69
Total Value
$507.00
Shares Held After
2,865
% of Holdings
10.5%
Innovative Eyewear, Inc. (LUCY)
Gayle Oswald — Chief Financial Officer
Shares
700
Price
$1.66
Total Value
$1.16K
Shares Held After
2,565
% of Holdings
27.3%
VEEVA SYSTEMS INC (VEEV)
Schwenger Thomas D. — Pres. & Chief Customer Officer
Shares
1,000
Price
$231.43
Total Value
$231.43K
Shares Held After
23,204
% of Holdings
4.1%
Acrivon Therapeutics, Inc. (ACRV)
Devroe Eric — Chief Operating Officer
Shares
10,000
Price
$1.72
Total Value
$17.22K
Shares Held After
75,308
% of Holdings
13.3%
Apellis Pharmaceuticals, Inc. (APLS)
Chopas James George — VP/Chief Accounting Officer
Shares
873
Price
$22.19
Total Value
$19.37K
Shares Held After
52,595
% of Holdings
1.6%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
1,780
Price
$22.19
Total Value
$39.49K
Shares Held After
83,058
% of Holdings
2.1%
Apellis Pharmaceuticals, Inc. (APLS)
Deschatelets Pascal — Chief Scientific Officer
Shares
2,277
Price
$22.19
Total Value
$50.52K
Shares Held After
1,158,219
% of Holdings
0.2%
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
10,186
Price
$22.19
Total Value
$226.00K
Shares Held After
321,419
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
2,618
Price
$22.19
Total Value
$58.09K
Shares Held After
81,046
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
3,856
Price
$22.19
Total Value
$85.55K
Shares Held After
107,080
% of Holdings
3.5%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
5,780
Price
$22.19
Total Value
$128.24K
Shares Held After
98,838
% of Holdings
5.5%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
1,923
Price
$21.08
Total Value
$40.54K
Shares Held After
22,408
% of Holdings
7.9%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
11,663
Price
$20.54
Total Value
$239.55K
Shares Held After
24,331
% of Holdings
32.4%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
4,440
Price
$19.45
Total Value
$86.37K
Shares Held After
35,994
% of Holdings
11.0%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
8,974
Price
$18.43
Total Value
$165.37K
Shares Held After
40,434
% of Holdings
18.2%
BioAge Labs, Inc. (BIOA)
Fortney Kristen — Director
Shares
233,107
Price
$18.12
Total Value
$4.22M
Shares Held After
976,949
% of Holdings
19.3%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
3,000
Price
$40.00
Total Value
$120.00K
Shares Held After
137,031
% of Holdings
2.1%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
23,279
Price
$40.00
Total Value
$931.16K
Shares Held After
312,883
% of Holdings
6.9%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
6,609
Price
$19.80
Total Value
$130.89K
Shares Held After
996,502
% of Holdings
0.7%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
5,861
Price
$19.80
Total Value
$116.07K
Shares Held After
882,418
% of Holdings
0.7%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
6,609
Price
$19.80
Total Value
$130.89K
Shares Held After
996,502
% of Holdings
0.7%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
5,861
Price
$19.80
Total Value
$116.07K
Shares Held After
882,418
% of Holdings
0.7%
Sharps Technology, Inc. (STSS)
Saba Capital Management, L.P. — 10% Owner
Shares
29,777
Price
$2.19
Total Value
$65.21K
Shares Held After
1,626,858
% of Holdings
1.8%
Immuneering Corp (IMRX)
Neufeld Leah R — CHIEF PEOPLE OFFICER
Shares
2,626
Price
$4.15
Total Value
$10.91K
Shares Held After
25,970
% of Holdings
10.1%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,800
Price
$29.83
Total Value
$53.69K
Shares Held After
5,604,102
% of Holdings
0.0%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
200
Price
$28.49
Total Value
$5.70K
Shares Held After
542,761
% of Holdings
0.0%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
49,800
Price
$27.60
Total Value
$1.37M
Shares Held After
542,961
% of Holdings
8.4%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$84.33
Total Value
$42.16K
Shares Held After
74,374
% of Holdings
0.7%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
40,796
Price
$15.95
Total Value
$650.77K
Shares Held After
126,644
% of Holdings
24.4%
Showing 601–650 of 1606 transactions (page 13 of 33)